• Home
  • About Us
  • Pipeline
  • Collaborations
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
  • Contact Us
  • Site Map
  • Home
  • About Us
  • Pipeline
  • Collaborations
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
  • Media Center
  • News Releases
  • Publications

Press Releases

Lexicon Pharmaceuticals Announces Real-World Data on Telotristat Ethyl’s Antiproliferative Effects in Patients with Carcinoid Syndrome Jan 24, 2020
Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium Jan 20, 2020
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Jan 06, 2020
Lexicon Pharmaceuticals Announces Topline Phase 3 Data for Sotagliflozin in Type 2 Diabetes Dec 20, 2019
Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211 Dec 05, 2019
Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of Tele-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer Dec 03, 2019
Lexicon Pharmaceuticals Receives Formal Dispute Resolution Request Decision from FDA’s Office of New Drugs for Sotagliflozin in Type 1 Diabetes Dec 02, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Nov 26, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Nov 14, 2019
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update Nov 07, 2019
  • 1
  • 2
  • 3
  • 4
  • ...
  • 6
  • 7
  • 8
  • 9
  • 10

Precision Science   »   Pioneering Medicine   »   Patient Driven

Thank you for your interest. Your e-mail will be added to our list for news alerts.
Sorry, our system is unable to handle this right now. Please contact us directly.
  • Home
  • About Us
  • Pipeline
  • Collaborations
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
Copyright © 2020, Lexicon Pharmaceuticals, Inc. All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Vendor Terms
  • Contact Us
  • Sitemap